Lindsey Durowoju, MD - "Hemoglobin Variants and Stool-Based Colorectal Cancer Screening"
Date of activity: 6/1/2022
Lindsey Durowoju, MD
Resident (PGY-3)
Department of Laboratory Medicine & Pathology
University of Washington
Objectives:
1. Describe stool-based colorectal cancer screen methods.
2. Identify health disparities associated with colorectal cancer screening.
3. Recognize the role laboratory medicine plays in reducing health disparities.
Speaker disclosures: Dr. Lindsey Durowoju has NOT had any financial relationships with any ineligible entities within the past 24 months.
**********************************************************************************
2022-2023 Laboratory Medicine Grand Rounds Planning Committee Disclosures:
The following members have not had any financial relationships with any ineligible entities in the past 24 months: Lindsey Durowoju, MD; Ashley Eckel, MD, PhD; Susan Fink, MD, PhD; Noah Hoffman, MD, PhD; Nabiha Huq Saifee, MD, PhD; Andrew Laitman, MD, PhD; and Cate Paschal, PhD.
The following members disclose financial relations with ineligible entities within the past 24 months: Sean Murphy, MD, PhD Sound Vaccines Inc. (Co-founder/equity); Daniel Sabath, MD RareCyte, Inc (Research support); Brian Shirts, MD PhD Sana Biotechnology, Inc. (consulting); Hamilton Tsang, MD Pfizer, Roche, Johnson and Johnson, CRISPR therapeutics (stock holder).
All relevant financial relationships listed have been mitigated.
Grant Acknowledgement: None
